Figure 9.Evaluation the value of the anoikis-related prognostic model in drug sensitivity and immunotherapy. (A–F) Correlation between risk score and drug sensitivity. (G–I) Differences in TIDE, Exclusion, and Dysfunction between low- and high-risk groups. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
